Antelope Surgical Solutions to Present at BIO International Convention 2025, June 6, 2025.
Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development, Jan 9, 2025.
Primo Biotechnology Partners with Antelope Surgical Solutions for First FDA-Approved Phase I/II Trial of AS1986NS, Dec 20, 2024.
Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval for PSMA-Fluorescent Novel Drug AS1986NS, Nov 12, 2024.
Follow us on LinkedIn.